Somatic hematopoietic TP53 mosaicism in women with breast cancer exposed to ionizing radiation

被引：0
|
作者：
Melnov, Sergey [1 ]
Murphy, Patricia [2 ]
Foley, Thomas [3 ,4 ]
Nadyrov, Eldar [5 ]
Kipen, Vyacheslav [1 ]
Leushev, Boris [1 ]
Modugno, Francesmary [6 ]
机构：
[1] Int Sakharov Environm Univ, Belorussian Sci Ctr Ecol, Minsk, BELARUS
[2] GeneWISE, Bar Harbor, ME USA
[3] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Endocrinol, Pittsburgh, PA USA
[5] Gomel State Med Univ, Dept Pathol, Gomel, BELARUS
[6] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
来源：
BREAST JOURNAL | 2018年 / 24卷 / 05期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1111/tbj.13056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：852 / 854
页数：3
相关论文
共 50 条
  • [21] Identification of novel TP53 regulated genes induced by ionizing radiation.
    Bourguet, F.
    Krefft, A.
    Peterson, L. E.
    Coleman, M. A.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2007, 48 (07) : 629 - 629
  • [22] TP53 haplotypes and susceptibility to breast cancer.
    Kristensen, Vessela
    Garcia-Closas, Montserrat
    Langerod, Anita
    Qi, Ying
    Yeager, Meredith
    Burdett, Laurie
    Welch, Robert
    Lissowska, Jolanta
    Peplonska, Beata
    Bardin-Mikolajczak, Alicija
    Brinton, Louise
    Gerhard, Daniela S.
    Perou, Charles
    Borresen-Dale, Anne-Lise
    Chanock, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [23] TP53 Mutation Patterns in Breast Cancer Subgroups
    Dumay, A.
    Feugeas, J-P
    Wittmer, E.
    Lehmann-Che, J.
    Bertheau, P.
    Espie, M.
    de Cremoux, P.
    Andre, F.
    Sotiriou, C.
    Pusztai, L.
    de The, H.
    CANCER RESEARCH, 2011, 71
  • [24] THE ROLE OF TP53 IN BREAST-CANCER DEVELOPMENT
    EELES, RA
    BARTKOVA, J
    LANE, DP
    BARTEK, J
    CANCER SURVEYS, 1993, 18 : 57 - 75
  • [25] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [26] TP53 status and response to chemotherapy in breast cancer
    Bertheau, Philippe
    Espie, Marc
    Turpin, Elisabeth
    Lehmann, Jacqueline
    Plassa, Louis-Francois
    Varna, Mariana
    Janin, Anne
    de The, Hugues
    PATHOBIOLOGY, 2008, 75 (02) : 132 - 139
  • [27] TP53 mutation in triple negative breast cancer
    Nikolaidou, A.
    Botsfari, E.
    Goupou, E.
    Rouptsiou, E.
    Iosifidou, R.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2017, 471 : S302 - S302
  • [28] TP53 as a predictor of response to chemotherapy in breast cancer
    Lonning, PE
    Johnsen, H
    Geisler, S
    Aas, T
    Smith-Sorensen, B
    Akslen, LA
    Borresen-Dale, AL
    PRIMARY MEDICAL THERAPY FOR BREAST CANCER: CLINICAL AND BIOLOGIC AL ASPECTS, 1999, 4 : 73 - 88
  • [29] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [30] Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women
    Khadang, Baharak
    Fattahi, Mohammad Javad
    Talei, Abdolrasol
    Dehaghani, Alamtaj Samsami
    Ghaderi, Abbas
    CANCER GENETICS AND CYTOGENETICS, 2007, 173 (01) : 38 - 42
12345